| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Pavel Raifeld
Also a director
Chief Executive Officer
|
42 |
Since 2020
6 years
|
Not stated | $5,400,197 | |
|
Stephen Basso
Chief Financial Officer & President of IST
|
60 | Not stated | Not stated | $2,171,276 | |
|
Marianne Zhen
Chief Accounting Officer
|
57 |
Since 2018
8 years
|
2014 | $1,082,859 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Mar 24, 2026 · updated by the 8-K of May 18, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Pavel Raifeld
CEO
|
42 |
2025
1 year
|
Not stated | None stated | None stated | Paid as CEO | |
|
Jules Haimovitz
|
75 |
2018
8 years
|
Independent |
Audit · Chair
|
Armata Pharmaceuticals, Inc. | $447,236 | |
|
Sarah J. Schlesinger, M.D.
|
66 |
2018
8 years
|
Independent |
Nominating/Corporate Governance · Chair
|
Armata Pharmaceuticals, Inc. | $396,851 | |
|
Josephine Linden
Joined May 18, 2026
|
- | - | Independent |
Audit Committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Mar 24, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...